A world of hope through accelerator- based science and technologies.

Slides:



Advertisements
Similar presentations
SUPERCONDUCTING RF (SRF) SYSTEMS Peter McIntosh (STFC) Accelerator-driven Production of Medical Isotopes 8 th – 9 th December
Advertisements

A world of hope through accelerator- based science and technologies.
An Association of Florida State University Accelerator Lab Hope College Ion Beam Laboratory Ohio University Accelerator Lab Texas A&M Cyclotron Lab TUNL.
ANSTO POST DOCTORAL FELLOWSHIPS 2 -Year Term Positions (with possible extension) Sydney Australia Australia's challenges in environmental sustainability.
Radiological and Experimental Facilities Based On INR Proton LINAC Institute for nuclear research of RAS, Moscow , Russia Sergey Akulinichev, Leonid.
PET/CT & PET/MRI Radiopharmacy
Nuclear Chemistry.
1 Nuclear and Particle Physics. 2 Nuclear Physics Back to Rutherford and his discovery of the nucleus Also coined the term “proton” in 1920, and described.
FFAG Fixed Field Alternating Gradient synchrotrons, FFAGs, combine some of the main advantages of both cyclotrons and synchrotrons:  Fixed magnetic field.
DIFFERENTIATE BETWEEN FISSION AND FUSION.
Nuclear Science in Africa
Nuclear Chemistry.
Nuclear Chemistry L. Scheffler. The Nucleus The nucleus is comprised of the two nucleons: protons and neutrons. The number of protons is the atomic number.
The Nucleus and Radioactivity
A facility for Nuclear, Atomic, Material and Radiobiology Sciences. Delivering stable (from C to U) and radioactive ions (from He to Xe) in the energy.
Chapter 2 Particle accelerators: From basic to applied research Rüdiger Schmidt (CERN) – Version E1.0.
Ion Beam Analysis Dolly Langa Physics Department, University of Pretoria, South Africa Blane Lomberg Physics Department, University of the Western Cape,
An Introduction To Particle Accelerators A-Level Physics.
Overview of Cyclotron Facilities
Heavy Ion Accelerator for RIB KoRIA in International Science & Business Belt S. W. Hong Sungkyunkwan University S. W. Hong Sungkyunkwan University Nov.
Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,
Isotope R&D Facility A proposed addition to the HRIBF driver upgrade Mike Saltmarsh HRIBF Users’ Meeting Nov 13 th 2009.
10-Year Vision: expanded RIB program with: three simultaneous beams increased number of hours delivered per year new beam species increased.
Institute of Heavy Ion Physics Kexin Liu November 5, 2008.
Nuclear Chemistry Chapter 21.
National Authority for Scientific Research IFIN-HH.
Duncan Weathers Department of Physics University of North Texas.
 Atomic Number  Protons + Neutrons = Atomic Mass.
NUCLEAR CHEMISTRY I.Unlike other chemical reactions that involve the transfer of electrons, nuclear reactions involve changes in the nucleus II.Transmutations-
Radioactivity Manos Papadopoulos Nuclear Medicine Department
Ragnar Hellborg Lund University PRODUCTION OF CLINICALLY USEFUL QUANTITIES OF 18 F BY AN ELECTROSTATIC TANDEM ACCELERATOR Ragnar Hellborg Lund University,
Production of innovative radionuclides at ARRONAX and 211 At RIT F. Haddad GIP ARRONAX.
Why Accelerator Mass spectrometry (AMS) The determination of the concentration of a given radionuclide in a sample can be done in 2 ways: a) measure the.
Search for low spin states at high excitation energies in 20 Ne with the p,t reaction iThemba LABS & Stellenbosch University Energy Postgraduate Conference.
The Radiotherapy Application NMT 232 L 8 1. Radiotherapy Generators Kilovoltage X-rays are generally used in the treatment of skin cancers and superficial.
NUCLEAR CHANGES. Nuclear Radiation Radioactivity: process by which an unstable nucleus emits one or more particles or energy in the form of electromagnetic.
Nuclear medicine Essential idea Nuclear radiation, whilst dangerous owing to its ability to damage cells and cause mutations, can also be used to both.
Atoms for Health Prof. Dr. Werner Burkart Skolkovo Conference on: Accelerators and Radiation Technologies for the Future of Russia Saint Petersburg,
Nuclear Stability and Decay 1500 different nuclei are known. Only 264 are stable and do not decay. The stability of a nucleus depends on its neutron-to-
Nuclear Chemistry Review. Isotopes of atoms can be stable or unstable. Stability of isotopes is based on the number of protons and neutrons in its nucleus.
1 RHIC NSRL LINAC Booster AGS Tandems STAR 6:00 o’clock PHENIX 8:00 o’clock 10:00 o’clock Polarized Jet Target 12:00 o’clock RF 4:00 o’clock (AnDY, CeC)
W. Udo Schröder, 2007 Applications Applications of Nuclear Instruments and Methods 1.
Nuclear Chemistry Review
European Organization for Nuclear Research
Design of a General Purpose I/O Controller for Particle Accelerators
The BLAIRR Irradiation Facility Hybrid Spallation Target Optimization
FRCR II - Radioactivity
ANSTO POST DOCTORAL FELLOWSHIPS
Great Ideas in Science: Lecture 7 – Nuclear Reactions
MeV Ion Microbeams and Radiation Biology at the University of Surrey
Status of AMS at iThemba LABS Gauteng
Design of a PET-isotope-based hadron therapy facility
Nuclear Chemistry Chemistry involving changes in the nucleus References: Text Chapter 19 Review Book Topic 12.
L 36 Modern Physics [3] [L36] Nuclear physics [L37] Nuclear energy
E = mc2 If you can’t explain it simply, you haven’t learned it well enough. Einstein.
Chain Reactions Chain Reaction - the series of repeated fission reactions caused by the release of neutrons in each reaction.
Nuclear Chemistry Chemistry involving changes in the nucleus References: Text Chapter 18 Review Book Topic 12.
Institute for Applied Physics National academy of sciences of Ukraine
OCR Gateway 2016 Physics topic 6
NPL accelerator facility
CS Introduction to Medical Computing
Department of Science & Technology (DST) Nuclear Skills Programme
Nuclear Reactions.
Nuclear Chemistry Chemistry involving changes in the nucleus References: Text Chapter 18 Review Book Topic 12.
Hadron Programs at HIRFL-CSR
Radioactive Decay Marie Curie and her husband Pierre discovered polonium and radium in The simplest decay form is that of a gamma ray, which represents.
Machine Sources of Radiation
Nuclear Chemistry The energy of life.
Unit 4 – Nuclear Reactions
Nuclear Chemistry.
Presentation transcript:

A world of hope through accelerator- based science and technologies. iThemba LABS: A world of hope through accelerator- based science and technologies.

Our aim is to be the leading African organisation for research, training and expertise in accelerator-based sciences and technologies. iThemba means HOPE, while LABS is the acronym for Laboratory for Accelerator-Based Sciences.

iThemba LABS is proud of its local and international status as a leading facility for accelerator-based sciences.

iThemba LABS: Key facts

The only producer in South Africa of accelerator-based radionuclides, radiopharmaceuticals for nuclear medicine and mainstream radiopharmaceuticals for positron emission tomography (PET) studies, houses the only PEPT-facility in the Southern hemisphere,

is home to a high-resolution magnetic spectrometer (K600) to measure proton energies in the 66 – 200 MeV range. A 0o-mode was recently added to expand capabilities, is the only facility globally to offer both protons and neutrons for particle therapy,

is the world’s only producer of current Good Manufacture Practise (cGMP) 68Ge/68Ga generators and 22Na-positron sources for annihilation studies, and supplies 25% of the world’s demand for 82Sr.

iThemba LABS has commissioned a beam-splitter facility – making it the 2nd facility in the world where particle beams are split and the ONLY facility where the beam rotator is utilised.

This will enable enhanced production – being able to irradiate two different target stations simultaneously.

iThemba LABS: Welcome to our world

iThemba LABS has facilities in two of South Africa’s provinces: the Western Cape and Gauteng.

The Western Cape centre houses: a 200-MeV Separated Sector Cyclotron (SSC), two injector cyclotrons (SPC1, SPC2) and a 6-MV Van de Graaff Accelerator.

Three user groups apply the particle beams delivered by the accelerators in: basic and applied research, particle radiotherapy for the treatment of cancer and production of radioactive isotopes for application in nuclear medicine and research.

A range of environmental samples is analysed using stable isotopes at the centre’s Environmental Isotope Laboratory. The analysis capabilities are enhanced through the availability of a 370 GBq Am-Be source for neutron activation studies.

iThemba LABS is a global player in the production of accelerator-based radionuclides. Much of its research and development is based on the availability of particle beams.

Production of the PARTICLE BEAM

It all starts at the ion source – the nuclei of hydrogen atoms. The nuclei are accelerated by an injector cyclotron before finally entering the Separated Sector Cyclotron (SSC) where they are accelerated to 66 MeV.

The SSC at iThemba LABS can accelerate protons to a maximum energy of 200 MeV. At this speed, a proton could travel four times around the earth in 1 second.

The 66-MeV proton beam has two end-stations (user communities) within iThemba LABS multidisciplinary facility. It is either used to generate neutrons through a collision with a Be-target or it is used to produce radionuclides through nuclear reactions with various solid targets.

Particle therapy PROGRAMME

iThemba LABS is the only facility in the Southern hemisphere offering both proton and neutron therapy as a treatment modality.

The neutrons generated are used for neutron therapy with the aid of a Gantry which allows the tumour to be irradiated from different directions. The floor in the treatment vault opens to allow the Gantry to rotate a full 360o.

The 200-MeV protons are used for fixed-beam proton therapy specialising in tumours located in the head and neck regions.

Radionuclide PRODUCTION

iThemba LABS is the leading African producer of: accelerator-based radiopharmaceuticals such as 123I, 67Ga and 81Rb/81mKr generators

18F-FDG and current Good Manufacture Practise (cGMP) 68Ge/68Ga generators for PET-studies 22Na-positron sources for annihilation studies, 82Sr and 88Y. 

iThemba LABS: Shaping the future

iThemba Labs is committed to: developing a beamsplitter capable of delivering two beams of different intensities, thereby increasing the production of radionuclides,

establishing an accelerator mass spectrometry (AMS) facility at iThemba LABS - Gauteng, the second in Africa, establishing a radioactive ion beam (RIB) facility to extend research capability and ensure competitive advantage.

iThemba LABS: A world of hope through accelerator-based science and technology.

For more INFO: Email: director@tlabs.ac.za or visit www.tlabs.ac.za